Phio Pharmaceuticals holds annual shareholder meeting via webcast
PHIO•Phio Pharmaceuticals held its annual shareholder meeting on Sept. 28, 2026. Shareholders approved increasing the 2020 long-term incentive plan’s share reserve by 1.5 million to 2,452,017 and ratified Grant Thornton for 2026.
1. Shareholder approvals
Shareholders approved an amendment increasing the 2020 long-term incentive plan’s share reserve by 1,500,000 to 2,452,017. The authorization took effect upon approval, and the filing did not confirm any awards had been issued under the expanded pool; shareholders also ratified Grant Thornton as the independent registered public accounting firm for the year ending Dec. 31, 2026.
